(UPDATED: See below.)
Oraya Therapeutics, a stealthy medical-device developer in Menlo Park, Calif., raised $4 million in a first funding round, VentureWire reports (subscription required). Essex Woodlands Health Ventures provided the funds.
From the VentureWire story:
Based in Menlo Park, Calif., Oraya is a stealth-mode medical device company founded in June 2006. According to the filing, the company’s board includes Essex Woodlands Partner Guido J. Neels and Adjunct Partner Michael E. Gertner.
Peter Cohn, a partner at the Menlo Park office of law firm Orrick Herrington & Sutcliffe LLP, was listed as secretary of Oraya.
UPDATE: This item still seems to draw a steady stream of traffic, so I thought I’d also direct readers to a later, more detailed item on Oraya’s second-round funding and the entrepreneurial background of founder Michael Gertner that we published in January.
Tags: co:Oraya, deal, inv:Essex-Woodlands-Health-Ventures, medical-devices2 Comments
-
Mark Wendman said:
more info on Oraya’s possible IP and here is a link to the founder via stanford
http://biod-01.stanford.edu:8080/bdn/people/gertner_michael.jsp
The hyperlink to my blog shows the patent applications and issued patents to the founder Dr. Michael Gertner over his career.
-
David Hamilton said:
Many thanks for your comment and the additional information on Oraya and Michael Gertner.
One Trackback
2:14 pm
VentureBeat » Secretive Oraya raises more funds for eye devices said:
[...] coverage of this newish VC firm here) and Essex Woodlands Health Ventures. We covered Oraya’s first round of funding last [...]